Supplementary Data for papers since 2013 not found below can be accessed here:
For access to any supplementary data prior to 2013, please email:
Fine Mapping Within eQTL Credible Intervals by eCROPseq
Detailed Methods
On the Utilization of Polygenic Risk Scores for Therapeutic Targeting
PLOS Genetics
Review Pre-Print
Comprehensive Multiple eQTL Detection and its Application to GWAS Interpretation
Table S2: Multisite effect estimates in the CAGE and FHS datasets
Transcriptional risk scores link GWAS to eQTLs and predict complications in Crohn’s disease, Nature Genetics volume 49, pages 1517–1521 (2017)
Supplementary Tables 1-5
Life Sciences
Reporting Summary
Supplementary
Text and Figures
1
2
3
4
5
Prediction of complicated disease course for children newly diagnosed with Crohn’s disease: a multicentre inception cohort study, The Lancet, Volume 389, Issue 10080, 29 April–5 May 2017, Pages 1710-1718
Supplementary
Material
A Burden of Rare Variants Associated with Extremes of Gene Expression in Human Peripheral Blood, AJHG, Volume 98, Issue 2, p299–309, 4 February 2016.
3
4
5
6
7
Supplementary Tables 3-7
Omic personality: implications of stable transcript and methylation profiles for personalized medicine: Genome Research, December 2015
Supplementary
Data
Omic Personality
Experimental Design
Transcriptomics and Metabolomics in a Rhesus Macaque Drug Administration Study: Frontiers in Cell and Developmental Biology: October 2014, Volume 2, Article 54
Supplementary Data 1
Transcript Abundance
Supplementary Data 2
Met Med Abundance
Supplementary Data 3
R & Matlab
Exome sequencing of patients with histiocytoid cardiomyopathy reveals a de novo NDUFB11 mutation that plays a role in the pathogenesis of histiocytoid cardiomyopathy: American Journal of Medical Genetics Part A: September 2015,Volume 167, Issue 9
Histiocytoid Cardiomyopathy Figures
Shehata et al
2013 AJHG
Supplementary
Table 3
Supplementary
Table 4